Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modelling and simulation in clinical drug development.
Rooney KF, Snoeck E, Watson PH. Rooney KF, et al. Among authors: snoeck e. Drug Discov Today. 2001 Aug 1;6(15):802-806. doi: 10.1016/s1359-6446(01)01855-4. Drug Discov Today. 2001. PMID: 11470589
Pharmacokinetics of ribavirin in patients with hepatitis C virus.
Wade JR, Snoeck E, Duff F, Lamb M, Jorga K. Wade JR, et al. Among authors: snoeck e. Br J Clin Pharmacol. 2006 Dec;62(6):710-4. doi: 10.1111/j.1365-2125.2006.02704.x. Br J Clin Pharmacol. 2006. PMID: 17118126 Free PMC article.
A comprehensive hepatitis C viral kinetic model explaining cure.
Snoeck E, Chanu P, Lavielle M, Jacqmin P, Jonsson EN, Jorga K, Goggin T, Grippo J, Jumbe NL, Frey N. Snoeck E, et al. Clin Pharmacol Ther. 2010 Jun;87(6):706-13. doi: 10.1038/clpt.2010.35. Epub 2010 May 12. Clin Pharmacol Ther. 2010. PMID: 20463660
Pharmacokinetics and pharmacodynamics of the non-nucleoside reverse-transcriptase inhibitor etravirine in treatment-experienced HIV-1-infected patients.
Kakuda TN, Wade JR, Snoeck E, Vis P, Schöller-Gyüre M, Peeters MP, Corbett C, Nijs S, Vingerhoets J, Leopold L, De Smedt G, Woodfall BJ, Hoetelmans RM. Kakuda TN, et al. Among authors: snoeck e. Clin Pharmacol Ther. 2010 Nov;88(5):695-703. doi: 10.1038/clpt.2010.181. Epub 2010 Sep 29. Clin Pharmacol Ther. 2010. PMID: 20881958 Clinical Trial.
Population analysis of the non linear red blood cell partitioning and the concentration-effect relationship of draflazine following various infusion rates.
Snoeck E, Piotrovskij V, Jacqmin P, Van Peer A, Danhof M, Ver Donck K, Woestenborghs R, Van Belle H, Van Bortel L, Van Gool R, Dupont AG, Heykants J. Snoeck E, et al. Br J Clin Pharmacol. 1997 Jun;43(6):603-12. doi: 10.1046/j.1365-2125.1997.00593.x. Br J Clin Pharmacol. 1997. PMID: 9205820 Free PMC article. Clinical Trial.
98 results